Inventor · disambiguated record
Lori S. Burton
Also filed as: BURTON LORI S
2 granted patents·6 pending applications·9 citations·filing 2005–2025
56Inventor score
Top patents by PatentIndex Score
8 records- 0186US7534763B2Sustained release GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 19, 2009·5 cites·25 claims
- 0282US11723975B2Compositions comprising an anti-LAG-3 antibody or an anti-LAG-3 antibody and an anti-PD-1 or anti-PD-L1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 15, 2023·4 cites·24 claims
- 0370US2024066123A1Compositions comprising an anti-lag-3 antibody or an anti-lag-3 antibody and an anti-pd-1 or anti-pd-l1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0461US2025152708A1Compositions comprising an anti-lag-3 antibody or an anti-lag-3 antibody and an anti-pd-1 or anti-pd-l1 antibodyBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0560US2025332252A1Antibody compositions and methods of use thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0651US2010022457A1Sustained release glp-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 0740US2006128726A1Process for preparing novel crystalline forms of (2S)-1-[[(7R)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl)pyrrolidine, novel stable forms produced therein and formulationsWANG XUEBAO·Filed 2005·Application pending·0 cites
- 0839US2019135905A1Compositions and methods for treating tauopathiesBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →